The Role of Generative AI in Personalized Medicine and Treatment Recommendations

Abstract

The advent of generative artificial intelligence (AI) is reshaping the landscape of modern healthcare, particularly in the domain of personalized medicine. Unlike traditional AI models that focus solely on classification and prediction, generative AI models—such as Generative Adversarial Networks (GANs), Variational Autoencoders (VAEs), and transformer-based architectures like GPT—possess the unique ability to generate new, meaningful data. This capability has profound implications for precision medicine, where treatment decisions must be customized to individual patients based on their genetic makeup, medical history, lifestyle, and other heterogeneous data. This paper explores the technical foundations and real-world applications of generative AI in personalized treatment planning, drug discovery, and synthetic data generation. It also presents a comparative analysis between conventional healthcare methods and AI-driven approaches, highlighting the superior speed, adaptability, and accuracy of the latter. Through an in-depth review of recent literature and case studies, we examine how generative models are being utilized to create virtual patients, design novel drug compounds, and simulate treatment outcomes with unprecedented precision. Furthermore, we propose a conceptual pipeline for AI-assisted treatment recommendation systems, incorporating multimodal data integration and real-time inference. While the potential is immense, the deployment of generative AI in clinical settings also raises important challenges related to model interpretability, bias, data privacy, and regulatory compliance. This paper concludes by discussing these limitations and offering a forward-looking perspective on how generative AI can be responsibly and effectively integrated into personalized medicine workflows

Ähnliche Arbeiten